Working… Menu

First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 (SYNFRIZZ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01469975
Recruitment Status : Terminated (Too slow accrual.)
First Posted : November 10, 2011
Last Update Posted : May 17, 2017
OncoTherapy Science, Inc.
Information provided by (Responsible Party):
Centre Leon Berard

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 3, 2015
Actual Study Completion Date : June 30, 2015

Publications automatically indexed to this study by Identifier (NCT Number):